These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38369392)

  • 1. Lassa fever vaccine use cases and demand: Perspectives from select West African experts.
    Kaboré L; Pecenka C; Hausdorff WP
    Vaccine; 2024 Mar; 42(8):1873-1877. PubMed ID: 38369392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Lassa Fever and Its Disease Management in West Africa.
    Reyna RA; Littlefield KE; Shehu N; Makishima T; Maruyama J; Paessler S
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced vaccine candidates for Lassa fever.
    Lukashevich IS
    Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for animal models for Lassa fever vaccine development.
    Lukashevich IS
    Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of candidate vaccines for the prevention of Lassa fever].
    Popova OD; Zubkova OV; Ozharovskaia TA; Zrelkin DI; Voronina DV; Dolzhikova IV; Shcheblyakov DV; Naroditsky BS; Logunov DY; Gintsburg AL
    Vopr Virusol; 2021 May; 66(2):91-102. PubMed ID: 33993679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lassa fever - the road ahead.
    Garry RF
    Nat Rev Microbiol; 2023 Feb; 21(2):87-96. PubMed ID: 36097163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lassa fever in West African sub-region: an overview.
    Ogbu O; Ajuluchukwu E; Uneke CJ
    J Vector Borne Dis; 2007 Mar; 44(1):1-11. PubMed ID: 17378212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassa fever amidst the COVID-19 pandemic in Africa: A rising concern, efforts, challenges, and future recommendations.
    Uwishema O; Alshareif BAA; Yousif MYE; Omer MEA; Sablay ALR; Tariq R; Zahabioun A; Mwazighe RM; Onyeaka H
    J Med Virol; 2021 Dec; 93(12):6433-6436. PubMed ID: 34289134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lassa virus diversity and feasibility for universal prophylactic vaccine.
    Lukashevich IS; Paessler S; de la Torre JC
    F1000Res; 2019; 8():. PubMed ID: 30774934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lassa Virus Countermeasures.
    Melnik LI
    Curr Top Microbiol Immunol; 2023; 440():111-145. PubMed ID: 36253593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
    Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.
    Salami K; Gsell PS; Olayinka A; Maiga D; Formenty P; Smith PG; Moorthy V
    Vaccine; 2020 May; 38(26):4135-4141. PubMed ID: 31952873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE).
    Duvignaud A; Jaspard M; Etafo IC; Serra B; Abejegah C; Gabillard D; Doutchi M; Alabi JF; Adedokun MA; Akinpelu AO; Oyegunle OO; Etafo J; Dede AO; Onyechi MN; Ireneh MU; Gbenga-Ayeni O; Fadiminiyi KG; Ehigbor PI; Ouattara E; Levy-Marchal C; Karcher S; N'guessan-Koffi L; Ahyi I; Amani E; Diabaté M; Siloué B; Schaeffer J; Augier A; Ogbaini-Emovon E; Salam AP; Horby P; Ahmed LA; Günther S; Adedosu AN; Anglaret X; Ayodeji OO; Malvy D
    Travel Med Infect Dis; 2020; 36():101557. PubMed ID: 31978611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The niche of One Health approaches in Lassa fever surveillance and control.
    Arruda LB; Haider N; Olayemi A; Simons D; Ehichioya D; Yinka-Ogunleye A; Ansumana R; Thomason MJ; Asogun D; Ihekweazu C; Fichet-Calvet E; Kock RA
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):29. PubMed ID: 33894784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine platforms to control Lassa fever.
    Lukashevich IS; Pushko P
    Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of Lassa fever vaccine candidates.
    Salami K; Gouglas D; Schmaljohn C; Saville M; Tornieporth N
    Curr Opin Virol; 2019 Aug; 37():105-111. PubMed ID: 31472333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.
    Salami KA; Mandi HE; Imbault N; Tornieporth NG
    Pan Afr Med J; 2022; 41():242. PubMed ID: 35734313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lassa fever vaccine.
    Fisher-Hoch SP; McCormick JB
    Expert Rev Vaccines; 2004 Apr; 3(2):189-97. PubMed ID: 15056044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.